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 Evaluation of the role of polyelectrolyte deposition 
conditions on growth factor release 
A.M. Peterson,a,b* C. Pilz-Allen,c H. Möhwaldb and D.G. Shchukind  
Polyelectrolyte multilayer coatings were prepared from solutions of poly(methacrylic acid) and 
poly-L-histidine. Bone morphogenetic protein 2 (BMP-2) was adsorbed to the surface of anodized 
titanium and polyelectrolyte multilayer coatings were built up on top of the BMP-2. The effect of 
deposition conditions on coating properties and preosteoblast response was measured by 
comparing coatings prepared under natural conditions to those prepared from solutions at pH = 
6.0 and solutions containing 0.1M NaCl. High levels of BMP-2 release were achieved, with coatings 
prepared from pH = 6.0 solutions releasing 86 ng cm-2 and coatings prepared from solutions 
containing 0.1M NaCl releasing 114 ng cm-2 over 25 days. Enhanced preosteoblast differentiation 
was observed on coatings prepared from modified solutions; however, this increased 
differentiation was apparent for BMP-2-eluting and control coatings. Additionally, a positive 
relationship between surface roughness and differentiation was observed, which may account for 
increased differentiation for systems that do not release BMP-2. 
Introduction 
As stents, bone scaffolds and hip and other implants become 
more widely used thanks to longer lifespans in the developed 
world, it is essential to improve the understanding of 
biointerfaces and to tailor the surfaces of implanted devices for 
specific applications. In the United States alone, 1.19 million hip 
and knee replacements were performed in 2011, a number that 
has doubled since 1995.1 Titanium is a popular choice for 
orthopaedic implant material given its strength, durability, and 
biocompatibility; however, implant lifetimes are limited because 
poor interfaces result in implant loosening. Limited integration 
of an implant with surrounding bone results from poor adhesion 
and growth of desires cells, either as a result of non-ideal surface 
properties or adhesion of bacteria and other undesired cells and 
proteins. Over the past two decades, significant strides have been 
made in developing improved biointerfaces.2–5 However, much 
is still unknown given the complexity of interactions at the 
implant-body interface. 
 Polyelectrolytes are polymers that contain ionically 
dissociable groups. Ions on strong polyelectrolytes are 
completely dissociated, whereas dissociation is pH-dependent 
for weak polyelectrolytes. Polyelectrolytes can contain 
positively (polycation) or negatively (polyanion) charged repeat 
units. Polyelectrolyte complexes (PECs) can be formed by 
depositing polycations and polyanions on a surface in an 
alternating fashion, resulting in a polyelectrolyte multilayer 
(PEM). PEC films and microcapsules have been used for a 
variety of applications, including drug delivery,6–10 
microreactors for synthesis of difficult to achieve crystalline 
nanomaterials,11–13 direct electron exchange between proteins 
and electrodes,14 and encapsulation of corrosion inhibitors for 
self-healing coatings.15–17 The properties of a PEM are 
dependent upon many processing parameters including 
polyelectrolyte pair, molecular weight,18–21 deposition pH,22 
salt/electrolyte concentration,23–28 and number of layers.29 With 
this in mind, the properties of the film can be tailored for a given 
application.  
 Given the biocompatibility of many polyelectrolytes, 
polyelectrolyte coatings have been used to improve the 
biocompatibility of implanted devices. Tryoen-Tóth et al. 
demonstrated that PEC coatings terminating in poly(styrene 
sulfonate) (PSS), poly(L-glutamic acid) (PGA) and poly(L-
lysine) (PLL) show good biocompatibility for osteoblast-like 
cells.30 Schultz et al. later reported a more regular and less 
obstructed fibroblast layer on PGA-terminated coatings as 
compared to PLL-terminated coatings. Additionally, by 
functionalizing the PGA layer with an anti-inflammatory 
peptide, in vivo production of an anti-inflammatory agent was 
detected.31 A PEC coating of hyaluronic acid and chitosan was 
developed by Chua et al. to confer antibacterial properties.32 
When arginine-glycine-aspartic acid was immobilized on this 
coating, osteoblast adhesion was also significantly improved as 
compared to pristine titanium.33 Additionally, Brunot et al. 
reported enhanced fibroblast activity on titanium coated with 
poly(styrene sulfonate)/poly(allylamine hydrochloride) 
multilayers.34 Other PEC coatings that have been shown to 
improve cell adhesion include chitosan/heparin35 and protamine 
sulfate/PSS.36 A number of recent reviews have highlighted the 
ability of polyelectrolyte multilayers to control cellular 
function.9,37–39 
 PEMs have also been used on implant surfaces for the 
controlled release of biologically relevant molecules such as 
drugs and growth factors. Macdonald et al. demonstrated the 
coating of a polymer scaffold with LbL-deposited poly(β-
aminoester) and chondroitin sulfate, a complex capable of 
delivering microgram scale amounts of BMP-2.40 Poly(L-lysine) 
(PLL)/hyaluronic acid (HA) coatings on a porous ceramic also 
showed microgram level release of BMP-2 from porous ceramic 
scaffolds. However, in this case over 60% of release was 
  
observed in the first day. Subsequent studies of the cross-linked 
PLL/HA coating on titanium surfaces showed cross-link density-
dependent release of BMP-2 as well as long term BMP-2 
stability (>1 year) when stored at 4°C.41 Microcapsules made of 
polyelectrolyte multilayers have also been used for controlled 
release of biologically relevant molecules.29,42–44 
 Direct comparison of the efficacy of PEM technologies is 
difficult because of the range of different substrates that have 
been used, some of which are porous scaffolds. The amount of 
growth factor release from porous scaffolds is reported per mass 
or volume of scaffold, while release from planar substrates is 
measured per surface area and release from microcapsules is 
related to the concentration of microcapsules. By using the same 
polyelectrolytes and adjusting processing parameters 
systematically, we can compare directly to our previous work 
and begin to describe protein diffusion mechanisms from PEMs 
where neither hydrolytic degradation nor cross-linking play a 
role.   
 Morphogens are biomolecules that act as spatial regulators 
and dictate cell behaviour and tissue development through 
concentration gradients. Morphogen gradients can cause cell 
migration, expression of different genes, and development of 
different tissues.45,46 Many morphogens, in particular 
transcription and growth factors, have been investigated for their 
ability to control osteoblast outcomes and bone formation.47–52 
One of these, Cbfa1, is an osteoblast-specific transcription factor 
that is essential for osteoblast differentiation as well as bone 
formation. Growth factors such as bone morphogenetic proteins 
(BMPs) have been implicated in Cbfa1 expression, and 
therefore, osteoblast differentiation.48 Hughes-Fulford and Li 
found that BMP-2 plays a critical role in stimulating 
mineralization.52 Other studies have confirmed BMP-2’s role in 
enhancing differentiation and extracellular matrix 
mineralization.48,51 Therefore, BMP-2 was selected as the growth 
factor of interest in this study. 
 The goal of this work is the controlled long term release of 
BMP-2 from PEM coatings so as to improve osseointegration 
and durability of titanium implants. Previously, we demonstrated 
microgram levels of release of a model polypeptide from a PEM 
coating.19 That coating was subsequently characterized and 
release of BMP-2 and basic fibroblast growth factor was 
achieved. Preosteoblast proliferation and differentiation were 
enhanced on the BMP-2-eluting coating.53 The following report 
investigates the formation, physical properties and preosteoblast 
response to PEM coatings prepared from modified solutions. In 
one case, the pH of deposition solutions was adjusted to pH = 6 
and in the other example 0.1 M NaCl was added to the solutions. 
The purpose of this work was to explore the effect of processing 
conditions on BMP-2 release from and surface properties of a 
PEM system and then to investigate the effect that these 
properties have on preosteoblast proliferation and 
differentiation. While it has long been known that varying 
solution conditions will affect PEM buildup, this tool has not 
previously been used for controlled release of growth factors. 
This report represents a proof of concept for the idea of adjusting 
BMP-2 release through changing deposition solution conditions. 
 
Experimental 
Materials 
Titanium foil (99.5% Ti) was acquired from Alfa Aesar. 
Poly(methacrylic acid, sodium salt) (PMAA, Mn ≈ 5400, PDI = 
1.8), poly-L-histidine hydrochloride (PH, molecular weight ≥ 
5000), phosphine buffered saline (PBS, pH = 7.4), α-modified 
Eagle’s medium (α -MEM), gentamicin, ascorbic acid,  glucose, 
bovine serum albumin (BSA), Triton X-100 and 
ethylenediaminetetraacetic acid (EDTA) were obtained from 
Sigma-Aldrich. Fetal calf sera and calf sera were obtained from 
PAA. 4% paraformaldehyde was obtained from BOSTER 
Biological Technology Ltd. Pronase and Casitron, the measuring 
buffer for cell counting, were purchased from Roche 
Diagnostics. Stains Alexa Fluor® 488 and TO-PRO®-3 were 
purchased from Invitrogen. Recombinant human bone 
morphogenetic protein 2 (BMP-2), the BMP-2 enzyme linked 
immune sorbent assay (ELISA) development kits and the ELISA 
buffer kit were acquired from Peprotech. The DiaSys Diagnostic 
Systems alkaline phosphatase (ALP) test kit was purchased from 
Rolf Greiner Biochemica GmbH. MC3T3-E1 pre-osteoblast 
cells were a gift from Ludwig-Boltzmann-Institute of Osteology.  
 
Titanium preparation 
Titanium foil was cleaned in 1.5 M sulphuric acid, then rinsed in 
deionized water, ethanol, acetone, and again in water. 
Anodization took place in 165 g L-1 sulphuric acid at a potential 
of 30 V for 5 min. Anodization under these conditions results in 
a porous oxide structure with pores ranging in size from 40-200 
nm in diameter.19  
 
Polyelectrolyte multilayer coatings 
Coating of titanium foil with the polyelectrolyte complex was 
achieved by first immersing the anodized titanium specimen in a 
0.1 mg mL-1 solution of BMP-2 in water for 15 minutes. The 
polyelectrolyte coating was then formed on top of this adsorbed 
layer by immersing the plate for 15 minutes in a 1 mg mL-1 
PMAA in water solution prepared under one of the conditions 
described below, then in a solution of 1 mg mL-1 PH in water for 
15 minutes. Specimens were washed three times in water 
between each adsorption step to remove weakly adsorbed 
material. Alternating layers of PMAA and PH were formed until 
10 layers (five bilayers) were achieved. Five bilayers were 
selected because films of this thickness were previously 
shown to be effective for loading and delivering 
significantly amounts of BMP-2, basic fibroblast growth 
factor, and a model polypeptide.53 As a control for cell 
culture, polyelectrolyte coatings without BMP-2 were also 
prepared. For these coatings, PH was adsorbed to anodized 
titanium as the first step, then five bilayers of PMAA/PH were 
formed on top of this PH layer. A schematic of the layer-by-layer 
formation of the PEMs is given in Figure 1  
 Coatings were prepared under two conditions: 1. Solution pH 
adjusted to 6.0; 2. 0.1M NaCl added to the deposition solutions. 
Specimens that were coated with solutions adjusted to pH = 6.0 
are denoted as PE-B6 (containing BMP-2) or PE-6 (control 
without BMP-2). Specimens that were coated with solutions 
containing 0.1M NaCl are denoted as PE-BN (containing BMP-
2) or PE-N. A pH of 6 was selected for two reasons. First, it is 
below the isoelectric point of BMP-2, meaning that BMP-2 has 
a net positive charge. However, pH = 6 is also above the pKa of 
PMAA, so the acid will be mostly dissociated.19  
 The results of this study are compared to previous work in 
which the polyelectrolyte and BMP-2 solutions were not 
modified. In this case, solutions of 1 mg mL-1  PMAA, 1 mg mL-
1
 PH and 0.1 1 mg mL-1 BMP-2 were prepared in DI water. These 
specimens are described as PE-B and PE for specimens with and 
without BMP-2, respectively. All PEMs were prepared at 22°C. 
 
Growth factor release 
To evaluate release of BMP-2 from PE-B6 and PE-BN coatings, 
specimens were immersed in PBS. Five specimens were 
monitored per condition. 1 mL aliquots were taken from the 
solutions regularly, with the aliquot volume replaced with fresh 
PBS. Aliquots were promptly frozen at -20 °C. The amount of 
growth factor released was quantified using enzyme linked 
immune sorbent assay (ELISA). ELISA was performed in 
accordance with the instructions provided with the development 
kit. Aliquots from the release studies were thawed and returned 
to room temperature immediately prior to their use in the assay. 
 
Cell culture and staining 
The MC3T3-E1 preosteoblast cell line was used to evaluate the 
biocompatibility of coatings. MC3T3-E1 cells were cultured on 
PE-B6, PE-BN, PE-6, PE-N, and anodized titanium surfaces. 
PE-6, PE-N and anodized titanium act as controls. Titanium and 
coated titanium specimens were sterilized using UV light and 
each specimen was placed in one well of a six well plate. 
MC3T3-E1 cells were cultured in α-MEM with 4.5 g L-1 glucose, 
10 vol.% fetal calf sera, 10 µg mL-1 Gentamicin and 50 µg mL-1 
ascorbic acid. Approximately 5.76x104 cells per well (6x10³cells 
cm-2) were suspended in culture medium, dispersed over the 
specimen and cultured for 3, 5, 7, 14 or 21 days in an incubator  
 
Fig. 1. Schematic of the layer-by-layer formation of PEMs.   
 
(Binder) at 37°C in a humidified atmosphere containing 5% CO2. 
Fresh medium was given every 2nd or 3rd day of culture.  
 Cells cultured for 7 days were stained and imaged with 
confocal fluorescence microscopy. Cells were fixed for 15 min 
in 4% paraformaldehyde, washed in PBS, permeabilized with 
0.1% Triton X-100 at 4°C for 15 min and washed three times in 
PBS. F-actin was stained with Alexa Fluor® 488 and cell nuclei 
were stained with TO-PRO®-3. Confocal micrographs were 
obtained with a Leica TCS SP confocal scanning system with a 
100x oil immersion objective (numerical aperture 1.4). 
 
Cell counting 
Cell counting was performed after 3, 5 and 7 days of culture. The 
titanium specimens with cells were first placed in new six well 
plates to avoid counting cells on the surface of cell culture wells. 
Cells on the specimen surface were detached with 500 µL 
Pronase/EDTA solution (0.001% Pronase/0.02% EDTA in 
PBS). The detached cells were transferred to 1.5 mL 
microcentrifuge tubes. The specimens were washed three times 
with 250 µL PBS. This PBS was also transferred to the 
microcentrifuge tubes. Cell/Pronase-EDTA/PBS suspensions 
were then centrifuged at 650 g for 10 min. The supernatant was 
removed and cells were redispersed in 200 µL PBS. 
Subsequently, 10 mL of the Casitron solution and 50 µL of the 
cell suspension were mixed. The number of cells in the resulting 
liquid were determined with a CASY Model TT cell counter 
  
(Roche Diagnostics). Cell counts were performed on three 
replicates per specimen and three specimens per condition. 
 
Alkaline phosphatase enzyme activity 
Preosteoblast differentiation and tissue formation were 
characterized with alkaline phosphatase (ALP) enzyme activity 
after 1, 2 and 3 weeks. The cell-seeded titanium surfaces were 
placed into new wells, washed with PBS, air-dried under laminar 
airflow for 30 min and frozen at -20ºC for 1 h. After freezing, 
cells were lysed with a 0.5% Triton X-100 solution for 20 min at 
room temperature. Then, 8 µL or 4 µL of the lysed product was 
added to 200 µL of the ALP enzyme working reagent. The ALP 
enzyme working reagent was incubated at 37ºC prior to mixing 
with the lysed product. Immediately after mixing, the absorbance 
of these samples was measured at 405 nm at 37ºC for ten minutes 
using a plate reader. Results are expressed in units of U L-1 and 
are normalized to a specimen surface area of 1 cm2. Three 
specimens were measured for each condition at every time point 
and the absorbance of these specimens was measured in 
triplicate.  
 
Coating analysis 
Coatings were characterized using scanning electron microscopy 
(SEM), atomic force microscopy (AFM), contact angle, and 
quartz crystal microbalance (QCM) analysis. QCM analysis was 
performed using a Q-Sense instrument on titanium sensors at a 
flow rate of 50 µl min-1 and temperature of 22 °C. Static and 
dynamic sessile drop methods were used to determine the static 
contact angles and the advancing and receding contact angles, 
respectively. 
 
 
 
 
Results and Discussion 
BMP-2 release 
The release of BMP-2 from PE-B6 and PE-BN is shown in 
Figure 2. Data from PE-B6 and PE-BN are also compared to data 
from the unmodified polyelectrolyte multilayer, PE-B.53 PE-BN 
is capable of the greatest amount of release, with 114±6 ng cm-2 
BMP-2 released after 25 days. 86±5 ng cm-2 was released from 
PE-B6 after 25 days. Both of these values are far higher than 
release from PE-B and are greater than the amount of vascular 
endothelial growth factor (VEGF) that was immobilized on 
titanium surfaces by Hu et al.54 The amount BMP-2 released per 
time point is shown in Figure 3. For simplicity, all of BMP-2 
release within the first day have been combined into one time 
point.  
 Similar release behaviour is observed in all systems: high 
release rate for the first day, medium release rate for days 1-4 
and low release rate after day 4. The ratios of high to medium  
Fig. 3. Amount of BMP-2 release per time point for PE-B6, PE-BN and comparison 
to PE-B. Error bars represent standard deviation.  
Fig. 2 Amount of BMP-2 release (A) for PE-B6, PE-BN and comparison to PE-B. Percentage of BMP-2 release (B) for PE-B6, PE-BN and comparison to PE-B. 
Error bars represent standard deviation. 
Fig. 4. Cell count over the first week of culture on surfaces prepared from pH = 6 
solutions or surfaces prepared from solutions containing 0.1 M NaCl. Cell counts 
are normalized to a nominal surface area of 1 cm2. Error bars represent standard 
deviation. * = p < 0.05, ** = p < 0.01.  
release rates range from 8.1 to 14.8, while the ratios of medium 
to low release rates fall over a smaller range (3.6-5.0). The 
release profiles follow a t1/2 law and are in good agreement (R2 > 
0.95 in all cases) with the Higuchi model. 
 Further analysis can be performed by comparing percent 
release, which is shown in Figure 2b. The results from these  
release studies indicate that all of these films are capable of 
sustained release. The time for 50% release for PE-B6 and PE-
BN are days 17 and 4, respectively. The behaviours of PE-BN 
and PE-B are identical within error. However, the curve for PE-
B6 in Figure 3 deviates from the other two curves after 4 days 
and is outside of standard deviation after 17 days. Release from 
PE-BN is therefore identical to that from PE-B and the difference 
in total mass release results entirely from the amount of BMP-2 
that is adsorbed. In this case, BMP-2 exhibits the behaviour of a 
charged macromolecule and shows increased adsorption under 
high salt conditions.28,55–57 The different release behaviour of 
PE-B6 most likely results from the different polyelectrolyte 
multilayer structure that is formed from solutions at pH = 6. 
 
Preosteoblast proliferation 
The proliferation of preosteoblasts was evaluated on BMP-2-
eluting surfaces. The results were compared to preosteoblast 
proliferation on non-eluting polyelectrolyte coatings and 
anodized titanium surfaces. Cell count results are summarized in 
Figure 4. After three days of culture, cells proliferated more on 
the PE-B6 surfaces than on the two controls (anodized titanium 
and PE-6, p < 0.01). However, this level of preosteoblast 
proliferation is statistically equivalent to proliferation on PE-N 
and PE-BN surfaces. After five days, proliferation on PE-6 and 
PE-B6 was equivalent and close to twice that of proliferation on 
anodized titanium. Concerning proliferation on anodized 
titanium, PE-N and PE-BN surfaces were statistically equivalent 
after five days. After seven days of culture, there is no  
Fig. 5. ALP enzyme activity on surfaces prepared from pH = 6 solutions and from 
solutions containing 0.1 M NaCl. ALP enzyme activity values are normalized to a 
nominal surface area of 1 cm2. Error bars represent standard deviation. * = p < 
0.05, ** = p < 0.01.  
statistically significant effect of the polyelectrolyte coatings or 
of growth factor release, except in the case of PE-BN. This 
condition demonstrates greater cell proliferation (p < 0.01) than 
the control (PE-N) and PE-B6. It is unclear why preosteoblast 
proliferate more on PE-BN than PE-B6 on day 7, but less on day 
5. One explanation could be that by day 7 more preosteoblasts 
have transitioned from proliferation to differentiation on the PE-
B6 surfaces as compared to PE-BN surfaces.  Since BMP-2 is 
primarily implicated in proesteoblast proliferation and the 
chemistry of all coating surfaces is identical, the observed 
differences in cell proliferation are most likely the result of 
differences in surface roughness.51,52 
 After seven days of culture, samples were stained and imaged 
using confocal fluorescence microscopy. A thick cell layer was 
observed on all surfaces. These images are provided in the 
Supporting Information. 
 
Alkaline phosphatase enzyme activity 
ALP enzyme activity was used as a marker for preosteoblast 
differentiation and tissue formation. Results for ALP enzyme 
activity on different surfaces after one, two and three weeks of 
culture are given in Figure 5. After one week of culture, the 
coatings releasing BMP-2 demonstrate significantly higher ALP 
enzyme activity than their respective control surfaces (p < 0.01). 
However, after two and three weeks, coatings without BMP-2 
show ALP enzyme activity comparable to the BMP-2-releasing 
coatings.  
 The enzyme activity on coated surfaces is significantly (p < 
0.01) higher than on anodized titanium surfaces. The ALP 
enzyme activity after three weeks for all coatings is greater than 
the activity previously reported for the BMP-2-eluting coating 
prepared from unmodified solutions.53 
 While these values are promising as compared to previous 
results, it is curious that the increased BMP-2 release did not 
result in higher ALP enzyme activity for the coatings capable of  
  
BMP-2 release. As mentioned in the discussion of preosteoblast 
proliferation, surface roughness most likely plays a role in the 
observed preosteoblast differentiation and tissue formation. 
 
Coating characterization 
QCM was used to quantify the amount of polyelectrolyte that 
was adsorbed per bilayer during the coating process. Results for 
PE-6 and PE-N are shown in Figures 6. Non-linear growth of the 
polyelectrolyte multilayer was observed with PE-6. This is often 
observed during formation of polyelectrolyte multilayers 
containing polypeptides such as PH.58–60 However, linear growth 
of the polyelectrolyte multilayer was observed for PE-N and was 
previously reported for the unmodified version of this coating, 
PE. The masses adsorbed are very close (542±119 vs. 499±33 ng 
cm-2) for PE and PE-N, while far more is adsorbed for PE-6 
(10.5±0.4 µg cm-2).53 This is a potential explanation for the 
differences in percentage of BMP-2 release seen in Figure 2b.  
Each bilayer of PE-6 is over an order of magnitude thicker than 
a bilayer of PE-N. However, the difference in BMP-2 release 
rates is not nearly this large. The main different in release rates 
occurs in the intermediate time period. There are comparable 
levels of burst release over the first 24 hours; however, from days 
1-4, the rate of release is significantly slower in the thicker case. 
The greater thickness of the PE-6 coating requires a longer time 
to diffuse through, resulting in decreased BMP-2 release. 
 AFM-based surface roughness results are given in Figure 7a. 
One interesting result is the effect of BMP-2 adsorption on 
roughness. For the unmodified and pH = 6 condition, adsorbing 
BMP-2 instead of PH as the first layer has a somewhat significant 
(p < 0.10) effect on root mean squared (RMS) roughness. In the 
unmodified system, BMP-2 adsorption increases roughness, 
while in the pH = 6 system BMP-2 adsorption decreases 
roughness. No difference in roughness was observed for the 
0.1M NaCl condition. These differences in effect of BMP-2 
adsorption on nanoscale roughness may result from the different 
Fig. 6. QCM results for mass adsorbed per bilayer during polyelectrolyte multilayer buildup. (A) Formation of polyelectrolyte multilayer from pH = 6 
solutions (PE-6)  and (B) solutions containing 0.1 M NaCl (PE-N). 
Fig.7. Comparison of (A) surface roughness prior to culture and (B) ALP enzyme activity after 21 days of culture for anodized titanium and polyelectrolyte 
multilayer-coated anodized titanium surfaces. Error bars represent standard deviation. * = p < 0.05, ** = p < 0.01. 
conformations of BMP-2 under the different deposition 
conditions.  
 In comparing Figure 7a to Figure 7b, which displays ALP 
enzyme activity after 21 days of culture, a general trend of 
increasing ALP enzyme activity with increasing RMS roughness 
can be observed. The condition that deviates from the trend is 
PE-6B, which has the second lowest RMS roughness, yet 
exhibits the highest ALP enzyme activity. In this case, it is 
possible that the enhanced tissue formation resulting from BMP-
2 release is inhibited by low surface roughness.  
 Static contact angles for all PEM-coated surfaces were on the 
range of 67-77°, suggesting that the surfaces are chemically 
similar. The only exception to this is the PE-6 surface, which has 
a static contact angle of 44.4°. It was also observed that the PE-
6 surface absorbed water during the contact angle experiments, 
so this aberration in contact angle values could be due to bound 
water in and on the PEM. Contact angle hysteresis for BMP-2 
containing coatings is greater than for coatings without BMP-2 
(23-30° vs. 15-19°). Therefore, on the microscale, coatings 
containing BMP-2 are rougher than coatings without BMP-2.61 
SEM micrographs and a table of contact angle values are 
provided in the Supporting Information. This roughness does not 
appear to affect preosteoblast differentiation. While SEM 
micrographs show more debris on the surfaces of coatings 
without BMP-2, the structure of the coatings containing BMP-2 
is rougher and more textured. Microscale roughness differences 
may result from uneven adsorption and perhaps even 
agglomeration of BMP-2. Additionally, this uneven adsorption 
could also impact the nanoscale roughness and is another 
possible explanation for the differences in roughness observed 
via AFM.  
  
Conclusions 
Polyelectrolyte multilayer coatings were prepared from solutions 
of PMAA and PH. The effect of deposition conditions on coating 
properties and preosteoblast response was measured by 
comparing coatings prepared under natural conditions to those 
prepared from solutions at pH = 6.0 and solutions containing 
0.1M NaCl. This is the first report in which the role of solution 
conditions on release behaviour and resulting cellular function 
has been investigated. In this way, surface chemistry was held 
constant while thickness, polyelectrolyte multilayer structure 
and surface roughness were varied. 
 High levels of sustained BMP-2 release can be achieved, with 
PE-B6 coatings releasing 86 ng cm-2 and PE-BN coatings 
releasing 114 ng cm-2 over 25 days. ALP enzyme activity is 
enhanced on coatings prepared from modified solutions, 
regardless of their ability to release BMP-2. Additionally, a 
positive relationship between surface roughness and ALP 
enzyme activity was observed. Controlling surface roughness 
and BMP-2 release simultaneously may result in further 
enhancement of preosteblast outcomes. 
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